CHIC

Category	European
Project Title	Computational Horizons in Cancer: Developing Meta- and Hyper-Multiscale Models and Repositories for In Silico Oncology
Funding Organization	EC
Programme	FP7, No 600841
Coordinator	Institute of Communication and Computer Systems – National Technical University of Athens (short name: ICCS) – Greece
Partners	European Research and Project Office GMBH (short name: EURICE ) – Germany Uninersitaet des Saarlandes (short name: USAAR) – Germany Katholieke Universiteit Leuven (short name: KU Leuven) – Belgium University of Bedfordshire (short name: BED) – United Kingdom The University of Sheffield (short name: USFD) – United Kingdom Foundation for Research and Technology Hellas (short name: FORTH) – Greece Gottfried Wilhelm Leibniz Universitaet Hannover (short name: LUH) – Germany The Trustees of the University of Pennsylvania (short name: USFD) – USA The Chancellor, Masters and Scholars of the University of Oxford (short name: UOFX) – United Kingdom Universita Degli Studi di Torino (short name: UNITO) – Italy Universitaet BERN (short name: UBERN) – Switzerland CUSTODIX NV (short name: CUSTODIX) – Belgium Philips Electronics Nederland B.V (short name: Philips) – The Netherlands University College London (short name: UCL) – United Kingdom SCS SRL (short name: SCS) – Italy Technological Educational Institute of Crete (short name: TEI-C) – Greece
Duration	01/04/2013 – 31/03/2017
Total Budget	13.907.967,00 €
TEI-Crete budget	78.320,00 €
Web Site	www.chic-vph.eu
Project Objective	The CHIC proposal aims at developing cutting edge ICT tools, services and secure infrastructure to foster the development of elaborate and reusable integrative models (hypermodels) and larger repositories so as to demonstrate benefits of having both the multiscale data and the correponding models readily available. Although the broader VPH domain is the primary target of the hypermodelling infrastructure to be developed by CHIC, the primary application domain will be cancer and in silico oncology. In the mid and long term CHIC aims to pave the way for reliable in silico clinical trials, lying at the heart of the vision of in silico medicine, and subsequently for patient individualized treatment optimization based on in silico experimentation.